Aprogen Biologics Inc. (KRX:003060)

South Korea flag South Korea · Delayed Price · Currency is KRW
293.00
-14.00 (-4.56%)
At close: Mar 4, 2026
-60.08%
Market Cap 60.65B
Revenue (ttm) 74.91B
Net Income (ttm) -194.29B
Shares Out 197.57M
EPS (ttm) -983.23
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,193,407
Average Volume 4,771,451
Open 298.00
Previous Close 307.00
Day's Range 272.00 - 301.00
52-Week Range 272.00 - 840.00
Beta -0.03
RSI 22.15
Earnings Date Mar 16, 2026

About Aprogen Biologics

Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea. The company was founded in 1960 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1960
Employees 391
Stock Exchange Korea Stock Exchange
Ticker Symbol 003060
Full Company Profile

Financial Performance

In 2024, Aprogen Biologics's revenue was 67.38 billion, a decrease of -22.88% compared to the previous year's 87.36 billion. Losses were -104.98 billion, -11.24% less than in 2023.

Financial Statements

News

There is no news available yet.